Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 55 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK PALFIJN from Heusden-Zolder, company number BE0454185573, closed financial year 2025 with a result of € 198,306 after tax. For that financial year APOTHEEK PALFIJN recorded a gross margin of € 327,739 and equity of € 141,270. Compared with financial year 2024, the result moved from € 121,907 to € 198,306. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.
€ 141,270
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 198,306
▲ 63% vs 2024
Profit after tax over the fiscal year.
€ 12,450
▼ 49% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 198,000 paid out
100 % of the profit went to the shareholders, mostly to APOTHEEK VALKENBORG (100 % of the shares). That is where the money ends up.
People and assets in 2025
€ 166,372
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.5 million
▲ 5% vs 2024
€ 109,624 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 268,978
▼ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,144
▲ € 4,851 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 236,424 | € 245,375 | € 212,772 | € 327,739 | ▲ 54% |
| Profit after taxes | € 185,620 | € 186,922 | € 121,907 | € 198,306 | ▲ 63% |
| Equity | € 77,134 | € 82,057 | € 140,963 | € 141,270 | |
| Total debts | € 946,704 | € 1,052,600 | € 1,890,687 | € 1,978,611 | ▲ 5% |
| Cash | € 12,819 | € 19,024 | € 24,591 | € 12,450 | ▼ 49% |
| Land & buildings | € 511,101 | € 604,745 | € 1,049,431 | € 1,067,168 | ▲ 2% |
| Retained profit | € 15,134 | € 20,057 | € 78,963 | € 79,270 | |
| Dividend | € 185,000 | € 182,000 | € 63,000 | € 198,000 | ▲ 214% |
| Bank debt | € 520,467 | € 596,994 | € 1,420,675 | € 1,486,879 | ▲ 5% |
| Balance sheet total | € 1,023,838 | € 1,134,656 | € 2,031,651 | € 2,119,881 | ▲ 4% |
Key figures of APOTHEEK PALFIJN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK PALFIJN?
What happened at APOTHEEK PALFIJN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Piet Verbrugghe stepped down as director. NBB
- Apotheek Valkenborg BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 198,306 (▲ 63% vs 2024). filed late Source: NBB ↗
- Piet Verbrugghe became a director. NBB
- Apotheek Valkenborg BV became a director. NBB
- New establishment in Heusden-Zolder. KBO
- Start of the company according to the CBE. KBO
In short
From € 185,620 profit in 2022 to € 198,306 profit in 2025.
Paid € 3,118 in corporate taxes since 2022.
Best year ever: 2025, with € 198,306 profit.
Paid out € 628,000 in dividends to the owners in total.
A new publication or filing at APOTHEEK PALFIJN? We notify you, reason included.
Follow APOTHEEK PALFIJNDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of APOTHEEK VALKENBORG comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK PALFIJNThe shares are held by APOTHEEK VALKENBORG (100%).
Directors
According to the 2025 annual accounts
Piet Verbrugghe
Director
since 2022 · until 2028
Managing director · represented by Kathleen Valkenborg
since 2022 · until 2028
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Meylandtlaan 159
3550 Heusden-Zolder
Meylandtlaan 155
3550 Heusden-Zolder
Active since 15 March 1995
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0454.185.573
- VAT number
- BE 0454.185.573
- Registered office
- Meylandtlaan 159, 3550 Heusden-Zolder
- Names & denominations
- APOTHEEK PALFIJN
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 December 1994
- Peppol
- Active · Active since 18 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers